Hoʻomaopopo ʻo Diabeton MV 60 mg; nā ʻōlelo i hoʻohana no ka hoʻohana ʻana i ka lāʻau lapaʻau ʻia i loko o ka hui o nā derivatives no ka lua o ka lua.
Hoʻohana nui ʻia ka hāmeʻa i ka mālama ʻana i ka maʻi diabetes, ka hoʻomohala ʻana i kahi hana kūʻokoʻa o ka insulin.
Hoʻopili ka hopena o kēia pūʻulu o nā lāʻau lapaʻau i ke kino o ke kanaka me ke kaʻina hana o nā pehu beta pancreatic, ka mea e hoʻoulu ʻia a me ka hana ikaika i ka insulin endogenous.
ʻO ka hoʻohanaʻana i nā derivatives o ka sulfonylurea e hele ana i mua o ka lawelawe pono ʻana a me ka hoʻopiha piha o nā beta i ke kino.
ʻO ka hana o kēia ʻano o nā lāʻau lapaʻau ka mea e hōʻike ai i nā hopena aʻe:
- ka hoʻoweliweli ʻana o nā hua beta pancreatic a me ka hoʻonui ʻana i kā lākou naʻau ma ka pae mū;
- ka hoʻonui ʻana o ka hana o ka insulin a me ka hana hoʻokipa o ka hormone e wāwahi iā ia (insulinase);
- nāwaliwali i ka pilina o ka insulin a me ka protein, e hōʻemi ana i ka pae o ka hoʻopaʻa ʻana o ka insulin i nā antibodies;
- komo i ka hoʻonui i ka mahele o ka musuli a me ka lipid kiko i kū i ka insulin;
- hoʻonui i ka nui o nā mea i hāʻawi i ka insulin i nā membran kiko;
- komo i ka holomua o ka hoʻohana ʻana i ka glucose i loko o ka naʻau a me nā ʻōpū;
- hōʻiliʻili i ka hana o ka gluconeogenesis ma loko o ka ate;
- i loko o nā lipid kaomi e hoʻopau i ka lipolysis a hoʻonui i ka nui o ka hoʻihoʻi ʻana a me ka hoʻihoʻi o ka glucose.
I kēia manawa, nui nā ʻano hua lāʻau i loaʻa mai ka sulfonylureas:
- ʻO nā lāʻau lapaʻau mua loa i hoʻohana ʻole ʻia i ka lāʻau lapaʻau hou - Tolazamide, Carbutamide.
- ʻO ka hanauna ʻelua, nona Glibenclamide, Gliclazide a me Glipizide he mau ʻelele.
- ʻO ke kolu ke kolamu o ka glimepiride.
ʻO kahi koho o ka lāʻau e hoʻohana ʻia e lawe ʻia e ke kauka hele mai.
He aha ka mea hypoglycemic agent?
ʻO ka lāʻau Diabeton ka lāʻau lapaʻau e hoʻohana ʻia e mālama i ka maʻi maʻamau ʻo 2.
Hiki ke hili ia i ka lāʻau i loko o nā ʻano like ʻole, e kau ana i ka nui o nā mea ikaika i ka hui - 60 a me 80 milligrams.
ʻO ka mea hana nui o ka gliclazide - kekahi o nā ʻelele o ka huaʻawa o ka ʻikepili sulfonylurea. ʻO ka hoʻokuʻu i ke ʻano o ka lāʻau lapaʻau nā papa ʻāpana.
Pono e hoʻomaopopo ʻia he Diabeton MV me kahi maʻi o 60 mg i hōʻike ʻia ma ke ʻano o ka lāʻau lapaʻau me kahi hoʻokuʻu hoʻololi.
Hoʻohana ʻia nā papa Diabeton i kēia mau hihia:
- ma ka loaʻaʻana o ka hopena i nā maʻi nā maʻi me ka maʻi ole e hoʻohana ʻole i ka diabetes mellitus;
- e pale i ka hoʻomohala ʻana o nā hoʻopiʻi o ka pathology, me ka hoʻokaʻawale ʻana i ka hopena o ka hōʻike o ka nephropathy a me ka retinopathy, ka hōʻeha a me ka infocococio miʻi
ʻO ka hana koʻikoʻi e ʻāpana o ka lāʻau lapaʻau e kōkua i ka hōʻemi o ka adhesion a me ka hoʻohui ʻana o nā platelets, ke kāpae i ka hoʻomohala ʻana o kahi trombus parietal a loaʻa ka hopena maikaʻi i ka hoʻonui ʻana i ka hana fibrinolytic.
Eia kekahi, i ka wā o ka maʻi, ua nānā ʻia ka normalization o ka vascular permeability.
Loaʻa nā pono o Diabeton MV 60:
- Loaʻa ia mau hiʻohiʻona antiatherogenic, ka mea e hōʻike iā ia iho i ke ʻano o ka normalization o ka cholesterol a me ka hoʻohaʻahaʻa ʻana i ka nui o nā radical manuahi.
- Mālama i ka nānā ʻana a me ke kūkulu ʻana o ka microthrombosis a me atherosclerosis.
- Hoʻēmi i ka maʻi vascular i ka adrenaline.
Ma hope o ka noi ʻana i ka lāʻau lapaʻau, ʻoi ka piʻi ʻana o ka neʻe i loko o ke kaila koko me nā hola ʻeono.
Nā ʻōkuhi no ka hoʻohana ʻana i ka lāʻau lapaʻau
ʻO ka lāʻau lapaʻau Diabeton mr 60 ka mea i loko o ka hoʻomehana hoʻomehana ʻana o nā patology wale nō i nā pākeke.
No kēlā me kēia mea maʻi, ke kauka nei ke kauka komo i kahi papa hana no ka lawe ʻana i ka lāʻau lapaʻau i ka wā o ka lapaʻau.
Pono nā koi maʻamau no ka hoʻohana ʻana i ka lāʻau lapaʻau i nā kuhikuhi no ka hoʻohana ʻana i ka lāʻau lapaʻau.
Wahi a nā ʻōlelo ʻōlelo no ka hoʻohana ʻana i ka lāʻau lapaʻau, pono e lawe ʻia ka lāʻau lapaʻau e pili ana i ka ʻatikala aʻe:
- I hoʻokahi lā lā, me ke ʻano o ka kau ʻana o ka meaʻai. I kēia hihia, ʻōlelo ʻia e hoʻohana i ke papa i ke kakahiaka, i ka wā kakahiaka.
- Lawe i nā papa maʻamau me ka nui o ka wai.
- Hiki i ka dosage i kēlā me kēia lā mai 30 a 120 mg o ka mea hana ikaika, ʻo ia ka mau papa 0.5-2 i ka manawa.
- Ka hoʻonā ʻia o ka lāʻau lapaʻau e hoʻonohonoho ʻia e ke kauka kauka no kēlā me kēia maʻi, e noʻonoʻo ana i nā hiʻohiʻona hiʻona o ke ʻano o ka maʻi.
- Inā aia ma lalo o nā kūlana kahi i hala aku ai ka lāʻau lapaʻau, ʻaʻohe pono e hoʻonui i ka papa maʻi aʻe
- ʻO ka hoʻomaka ʻana o ka lāʻau lapaʻau ʻoi aku ka maikaʻi e hoʻomaka me ka haʻahaʻa haʻahaʻa haʻahaʻa loa, ʻo ia ka hapalua o ka papa Diabeton MV 60 mg. Eia kekahi, hiki ke hoʻohana i kēia dosage e mālama i ka hopena makemake e like me ke mālama kākoʻo.
- Pono e hoʻonui pinepine ʻia nā ʻōpiopio mai kanakolu milligrams o ka mea ikaika. Ma hope o kekahi manawa manawa, hoʻoholo ka mea lapaʻau e hoʻonui mua iā ia i 60 mg, a laila ma 90 a me 120 mg o ka mea ola. Pono e hoʻomaopopo ʻia ma hope o ka hoʻomaka ʻana o ka mālama lapaʻau ʻana, hiki ke piʻi mua i ka nui o nā dosages ma mua o hoʻokahi mahina ma hope aku.
- ʻO ka palena kiʻekiʻe loa o kahi lāʻau lapaʻau i kēlā lā i kēia lā he 120 mg.
I kekahi mau hihia, ulu nā lāʻau hui. Hiki ke hoʻohana pū ʻia ka papa lāʻau Diabeton MV 60 i ka launa pū me nā lāʻau mai nā pūʻulu biguanide, nā mea paʻa alpha glucosidase, a i ʻole he lāʻau maʻi insulin.
No kekahi mau pūʻulu o nā maʻi, pono paha i nā hoʻoponopono i hōʻike ʻia i loko o ka annotation e pono ai. E pili ana kēia:
- nā kānaka me nā maʻi koʻikoʻi;
- i ka poʻe e pilikia ana e kūkulu i ka hypoglycemia.
ʻO ka māhele o ka poʻe i hōʻemi i ka hoʻomohala ʻana i ka hypoglycemia me nā mea maʻi me kahi kīnā ʻole ʻole, pili i nā meaʻai paʻa a i ka hoʻokē ʻai ʻana hoʻi, nā maʻi endocrine, carotid arteriosclerosis.
Hiki ke hoʻohana ʻia ka papa i ʻāpana paʻakikī e hoʻokō i kahi hopena hypoglycemic kūpaʻa a i ʻole kekahi pale ʻana i ke kūpaʻa ʻana o nā pilikia o ka pathology. Hiki i kekahi mea mālama olakino ke kuhikuhi i ka ʻoihana e hoʻohana ai i ka metformin hydrochloride, alpha-glucisidase inhibitors, a i ʻole thiazolinedione derivatives.
Ke hoʻohana nei i ka lāʻau lapaʻau, pono ia e kiaʻi pinepine i ka hoʻokaʻawale o ka glucose i ke koko i mea e pale aku ai i ka hoʻomohala ʻana o ka hypoglycemia.
I nā hihia hea i pāpā ʻia ai ka hoʻohana ʻana i kahi mea hypoglycemic agent?
E like me kekahi lāʻau lapaʻau, loaʻa ka Diabeton MV 60 i kahi papa inoa o nā contraindications no ka hoʻohana ʻana.
ʻOiai he papa inoa inoa nui o nā hōʻino maikaʻi o ka lāʻau, pono ia e noʻonoʻo i nā ʻano like ʻole o nā hiʻohiʻona maikaʻi e hiki mai ana ma hope o kona hoʻohana.
ʻO ka mea mua, pono ia e mālama pono i ka papa inoa o nā papa i lalo o ke ʻano o ka lāʻau lapaʻau me ka hoʻohana ʻana i kēia lāʻau lapaʻau.
I waena o nā contraindications nui e pili ana i kēia mau ʻano:
- ʻano maʻi diabetes mellitus 1;
- ma ka hihia o ke nānā ʻana i ka ketoocytosis maʻi i ke ʻano a i ʻole ke ʻano o kahi kupuna hānai i kahi mea maʻi;
- ka hōʻike ʻana o ka hypoglycemia ma kahi mea maʻi;
- i ka mua o nā heleʻana o kahi ʻano maʻi;
- maʻi ikaika a palu paha ka ulu ʻana;
- intolerance a hypersensitivity paha i hoʻokahi a hapa iki o ka lāʻau lapaʻau;
- leukopenia;
- i ka mokuʻāina ma hope o ka huli ʻana no ka pancreatic;
- ʻOiai e lawe ana i ka miconazole;
- i ka heleʻana o ka lactose intolerance aiʻole lactase nele.
I kēia lā, ʻaʻole lawa ka ʻike e pili ana i ka hana a kēia lāʻau lapaʻau i ka mālama ʻana i ka maʻi diabetes i nā keiki. No laila ʻo ke kumu ke kuhikuhi ʻole nei i ka lāʻau no kēlā mau maʻi (a ʻoi aʻe he ʻumikumamāwalu mau makahiki). Eia kekahi, nā contraindications e lawe pū i ka lāʻau lapaʻau no nā kaikamahine hāpai a me nā wahine i ka wā o ka hoʻoulu ʻana.
Eia kekahi, me ka makaʻala nui, kuhikuhi ka lāʻau i kēia mau hihia:
- Inā he nui aʻe ka hopena o ka hypoglycemia.
- Inā loaʻa nā mea e pono ke hoʻololi i ka luhi o ka mea maʻi i nā inikini insulin.
- Ma hope o kaʻaila wawaahi.
Eia kekahi, me ka mālama nui, pono e hoʻohana ʻia ka lāʻau inā loaʻa ka maʻi i nā maʻi o ka ʻōnaehana.
Hiki paha nā hopena maikaʻi loa
Hōʻike pinepine nā loiloi o nā mea maʻi e hoʻohana ana i ka lāʻau lapaʻau.
Hōʻike nā loiloi o nā kauka hiki ke kūpono ʻole i kahi lawelawe olakino ke alakaʻi i ka hoʻomohala ʻana i nā ʻano ʻano like ʻole, ʻo ia nā hopena.
Hiki i nā ʻokoʻa ma ka hana maʻamau o nā ʻokoʻa āpau a me nā ʻōnaehana hiki ke kū me ka pinepine o ka nui a me ka paʻakikī.
ʻO nā huaʻōlelo maikaʻi ʻole e loaʻa:
- kahi hōʻike ʻana i ka hana o ka hāliʻi ʻia hōʻike ʻia ma ke ʻano o ka manaʻo o ka kaumaha i loko o ka ʻōpū, ʻeha i loko o ka ʻōpū, ka ʻoni metallic i loko o ka waha waha, belching, hōʻea, ka luaʻi a me ka maʻi paha;
- hiki ke hoʻololi kino ka maʻi i ka hoʻomaka ʻana o ka mālama ʻana i ka therapeutic i ke ʻano o ka purpura, ka mālama ʻana i ka ʻili a i ʻole urticaria, hoʻonui ʻia photosensitivity, erythema, edema Quincke;
- nā hopena maikaʻi ʻole mai ka pūnaehana paahana i loaʻa i nā hōʻailona ma lalo nei - thrombocytopenia, hemolytic anemia ma diabetes mellitus, leukopenia, erythropenia;
- pilikia paha me ka hana maʻamau o ka puʻuwai e kū mai a me nā maʻi e like me ka hepatitis a i ʻole ka cholestatic jaundice e ulu;
- ka loaʻa ʻana o nā pilikia transient o nā kino ʻike;
- ke koho pono ʻole o ka make ʻana o ka lāʻau lapaʻau e alakaʻi i ka hoʻolālā ʻana o ka hypoglycemia, kona mau hōʻailona nui ke ʻano o ke ʻano maʻi, ka luhi, nā lūlū, nā lima haʻalulu, ka manaʻo ākea o ka luhi me ka nui o ke hiamoe;
- kahi hoʻonui kiʻekiʻe ʻana i ke kaupaona kino.
ʻO kahi ʻōmole nui o ka lāʻau e hele pū me nā hōʻailona aʻe:
- Hoʻonui kaho.
- ʻO ka manaʻo mau o ka pōloli.
- Kamaʻilio me ka noʻonoʻo naʻau.
- ʻO ke ʻano o nā pilikia me ka hiamoe.
Me kahi overdose, hiki i ke nānā a me ka hoʻonui ʻana i nā hōʻailona o ka hypoglycemia.
He aha nā lāʻau lapaʻau e hiki ke hoʻololi i ka lāʻau hypoglycemic?
Hiki ke ʻano ke kumukūʻai o ka lāʻau lapaʻau Diabeton MV mai 280 mau rubles i nā lāʻau lapaʻau ākea ʻē aʻe.
ʻO ka mea hana nui o ka lāʻau lapaʻau ka lāʻau lapaʻau e hoʻohaʻahaʻa i loko o Farani.
Ma muli o ke kumu i lawe ʻia mai ai i ka lāʻau, makemake nui nā poʻe maʻi inā he ʻenehana kikowaena kūloko a he aha kā lākou kumukūʻai?
ʻO nā mea nui no nā lāʻau lapaʻau nā papa pili home.
- MV Diabefarm;
- Glidiab a me kahi ʻano i hoʻololi ʻia o Glidiab MV;
- Gliclazide-acos MV;
- Hula.
I kēlā me kēia o nā lāʻau lapaʻau i luna, aia ke ʻano hana o Gliclazide.
Ke kīʻaha (60 mau papa) ʻO Glidiab me kahi pāʻālua o 80 mg mau kumukūʻai e pili ana i ka 120 rubles. ʻO ka mea hana i ka lāʻau lapaʻau ka Russian Federation. ʻO ka hoʻopiʻi piha piha o ka lāʻau Diabeton 80.
Hoʻololi ka papa ma Gliclazide MV i kahi mea hoʻoponopono hoʻololi hypoglycemic hoʻololi. Hoʻokumu ka lāʻau lapaʻau ma ke kumu o gliclazide a hiki ke loaʻa i nā ʻano like ʻole o ka mea ikaika (30 a 60 mg). ʻO kāna hana nui, ʻo ia ka hana ʻana i ke kaila koko ma ke ʻano o ka kīnā ʻana o ka meaʻai a me ka hana kino. ʻO ke kumu o kahi lāʻau lapaʻau ka haʻahaʻa ma mua o ke kumukūʻai o ka maʻi Diabeton MV a ma waena o 128 rubles.
Hiki ke kūʻai ʻia ka mea kikowaena Lūkini o Diabefarm MV ma nā hale kūʻai o ke kūlanakauhale no kahi o 130 rubles (60 papa). ʻAʻole ʻokoʻa nā huahana tabletted i ka hoʻopili (ʻo ka māhele like like, akā like ka ʻokoʻa i nā mea hoʻonani), nā hōʻailona, contraindications a me ka hiki o nā hopena kūpono mai ka lāʻau Diabeton MV.
I kekahi mau hihia, hiki ke loli ke kauka hele i ka lawe ʻana i nā papa Diabeton MV me nā maʻi ʻē aʻe.
- Mai ka hui sulfonylurea, akā me kekahi mea kanu ikaika компон
- ʻO kahi lāʻau lapaʻau mai kahi pūʻulu'ē aʻe, akā me nā waiwai lāʻau lapaʻau like like (glinides) ꓼ
Eia kekahi, hiki ke hoʻololi ʻia ke hoʻohana ʻana o ke Diabeton MV me nā lāʻau lapaʻau me kahi kuʻuna like like o ka hoʻolaha (DPP-4 inhibitors).
Pehea e hana ai ka lāʻau lapaʻau hoʻohaʻa ʻana i ke kōkia ʻo Diabeton MV e kekahi loea i ka wikiō ma kēia ʻatikala.
